Crystal Crop Protection Invests ?100 Crore in Gujarat: The company has acquired 31 acres in Jhagadia to establish a state-of-the-art, fully automated formulation and technical manufacturing plant with a scalable capacity of up to 120,000 TPA Tagros Acquires Bayer’s Flubendiamide Business: Tagros has signed a global deal to acquire Bayer’s Flubendiamide assets, including major brands like BELT and FAME, marking its entry into the branded B2C segment
Crystal Crop Protection has acquired 31.06 acres of land and assets from Kurl-On Ltd. in Jhagadia, Bharuch district, Gujarat, to establish a new greenfield agrochemical manufacturing facility.
Investment & Project Scope
The company plans to invest INR 100 crore over the next three years to develop a fully automated, world-class formulation and technical manufacturing plant. The project marks a strategic expansion of Crystal Crop’s production footprint in India.
New Production Capacity
Existing Manufacturing Capacity
Formulation Capacity: Before the Jhagadia expansion, Crystal Crop Protection operated formulation plants in Sonepat (Haryana), Jammu (J&K), and Anand (Gujarat), with a combined annual formulation capacity of approximately 60,900 MT/KL for crop protection products.
Technical (Active Ingredient) Capacity: The company also maintains backward-integrated technical manufacturing facilities in Sonepat (Haryana), Nagpur (Maharashtra), and Dahej (Gujarat), with a combined annual technical production capacity of around 6,600 MT, supporting its formulation operations.
Market Focus
The new facility will cater to:
The plant will manufacture key crop protection products, including:
Prominent brands expected to be produced at the facility include Topper, Tilt, Proclaim, Missile, and ACM 9.
Strategic Advantage of Gujarat
According to Executive Chairman & Managing Director Ankur Aggarwal, the Jhagadia facility strengthens the company’s long-term manufacturing strategy. Gujarat was selected due to:
The plant also benefits from proximity to major ports such as Dahej Port, Hazira Port, and Jawaharlal Nehru Port Trust (JNPT), enhancing export logistics.
Godrej Agrovet is strategically strengthening its crop protection business despite a prolonged slowdown in the agrochemical industry caused by erratic weather patterns and lower farm incomes. The company is expanding its crop coverage from 5–6 crops to nearly 10 crops through new product launches and label expansions. A third manufacturing facility in Dahej, Gujarat, is set to become operational to support higher production volumes.
In FY25, the crop protection segment reported revenue of INR 764 crore, reflecting a 6.2% year-on-year decline, highlighting the challenging demand environment.
New Product Launch: TAKAI
A key driver of the company’s revival strategy is the launch of TAKAI, an insecticide developed in collaboration with Ishihara Sangyo Kaisha Ltd. (ISK Japan). Powered by Cyclapryn (Cyclaniliprole) technology, TAKAI targets major pests in crops such as rice, maize, chickpea, and soybean. Field data indicate:
This innovation is aimed at improving farm productivity and strengthening the company’s portfolio in key crop segments.
Rallis India Limited has introduced two new insecticides ALSTOR and FIPLAM expanding its crop protection portfolio and reinforcing its focus on farmer-centric, high-performance solutions.
ALSTOR: Targeted Protection for Paddy
ALSTOR is a dual-action granular insecticide combining Chlorantraniliprole 0.4% and Fipronil 0.6%. It is specifically designed to control stem borer in paddy, one of the most damaging pests in rice cultivation.
The product has been strategically launched for the Rabi paddy season across Southern and Eastern India, where stem borer infestation significantly affects yields. Its granular formulation ensures early-stage crop protection and consistent field performance.
FIPLAM: Broad-Spectrum Pest Control
FIPLAM features a patented broad-spectrum formulation (Fipronil 12.5% + Lambda 5% ZC) targeting both sucking and chewing pests, including thrips, jassids, and borers. It is suitable for key crops such as: Cotton, Tomato, Chilli, Onion.
The product is being rolled out nationwide with a structured pricing and positioning strategy to ensure accessibility across diverse agro-climatic regions.
Bayer CropScience Limited announced its unaudited financial results for the third quarter (Q3) and nine months ended December 31, 2025.
Q3 FY 2025–26 Performance
Revenue grew by 5% year-on-year, primarily driven by strong performance in the corn seeds business. However, weather volatility, including excess rainfall, limited spray windows and impacted crop protection demand. Weak demand in chili and grape crops also weighed on performance.
Nine-Month Performance (April–December 2025)
Vice Chairman & MD Simon Wiebusch highlighted the company’s focus on portfolio resilience, new product launches, and cost discipline.
Executive Director & CFO Vinit Jindal noted that Profit After Tax grew 180% quarter-on-quarter (24% year-on-year), supported by improved sales mix, stabilized input costs, and stronger working capital management.
Best Agrolife Limited announced its financial results for the quarter and nine months ended December 31, 2025, highlighting weather-related challenges while emphasizing patented product growth and operational efficiency.
Q3 FY26 Performance
Sales declined due to excessive and erratic rainfall in October 2025, floods in Punjab and Haryana, low pest incidence in paddy and Rabi crops, and weaker farm incomes. Elevated generic inventory in the trade also intensified price competition.
9M FY26 Performance
Operational & Strategic Highlights
The company also secured multiple patents for novel combination formulations and process patents, including Nano-Urea and Para Benzoquinone, strengthening its innovation pipeline.
Despite short-term climatic and demand headwinds, Best Agrolife remains focused on patented products, cost optimization, and disciplined working capital management. The company plans to launch three additional patented combinations in the next 3–9 months, aiming to drive growth recovery and long-term value creation.
India Pesticides Limited reported robust financial performance for the quarter and nine months ended December 31, 2025, driven by strong export demand, volume growth, and capacity expansion initiatives.
Q3 FY26 Highlights
Growth was primarily volume-led, with overall volume increasing by ~32%. Export sales rose to INR 96 crore (from INR 75 crore YoY), driven by strong demand from the European Union and Australia. Domestic sales increased to INR 129 crore (from INR 97 crore YoY), supported by herbicides and intermediates.
Technical & API segments contributed 73% of total revenue, reflecting the company’s strong technical manufacturing base.
9M FY26 Performance
Improved capacity utilization (~65% in Q3) and operational efficiencies supported margin expansion.
Strategic & Operational Updates
The company targets ~20% revenue growth in FY27 with EBITDA margins in the 18–20% range and has a long-term vision to achieve INR 3,000 crore revenue by FY31.
UPL Limited reported another strong quarter in Q3 FY26, driven by broad-based EBITDA growth, margin expansion, and disciplined financial management. The company reaffirmed its FY26 guidance, citing sustained operational momentum.
Q3 FY26 Highlights
Performance was driven by improved product mix, higher capacity utilization, and lower input costs.
Segment & Platform Performance
UPL Corporation and UPL SAS also reported positive growth, supported by operational efficiency and improved margins despite macro and monsoon-related headwinds.
9M FY26 Performance
Insecticides (India) Limited (IIL) announced its financial results for Q3 and nine months ended December 31, 2025, reporting steady revenue growth despite challenging industry conditions.
Q3 FY26 Highlights
Growth during the quarter was largely volume-led, reflecting resilient demand in institutional (B2B) business, while retail (B2C) demand remained subdued.
Operational & Strategic Highlights
5 new products launched in 9M FY26, strengthening the innovation pipeline
Key launches such as Sparcle (Collaboration with Corteva), Centran, and Torry Super (Herbicide) saw encouraging farmer adoption
Insecticides - Sparcle (Triflumezopyrim), and Centran (Fipronil 15% + Chlorantraniliprole 5% SC) – Paddy Crop
Management described margin compression as temporary and expects gradual improvement. With a strengthened product portfolio, disciplined execution, and sustained farmer engagement initiatives, the company remains confident of delivering profitable growth over the medium term.
Meghmani Organics Limited (MOL) reported mixed performance for Q3 FY26, with profitability impacted by weak export demand, while nine-month earnings showed strong growth.
Q3 FY26 Performance
Export volumes remained under pressure due to softer global demand and uncertainty around U.S. trade policy, resulting in lower capacity utilization across segments.
Segment Performance:
Crop Protection (79% of revenue):
Pigments (21% of revenue):
The pigments segment faced margin pressure due to elevated raw material costs and weaker price realizations, further impacted by the withdrawal of anti-dumping duties (ADD) in Titanium Dioxide (TiOINR ).
9M FY26 Performance
Despite Q3 headwinds, strong performance in earlier quarters supported significant nine-month earnings growth.
Strategic & Outlook Highlights
Coromandel International reported strong revenue growth in Q3 FY26 despite challenges such as late monsoon withdrawal, rising raw material prices, and rupee depreciation. The company-maintained leadership across fertilisers, crop protection, specialty nutrients, bio-products, and agri-retail.
Consolidated Performance
Q3 FY26:
9M FY26:
The Board approved an interim dividend of INR 9 per share (900% on face value of INR 1).
Crop Protection Business Performance
Growth was supported by strong demand for key molecules in domestic and export markets. The company expanded capacity for a key technical molecule and plans further augmentation. Subsidiary NACL Industries completed a INR 249 crore rights issue.
Sharda Cropchem delivered a strong performance in Q3 and 9M FY26, driven by volume growth and improved product mix, achieving its highest-ever annual Profit After Tax within the first nine months of the fiscal year.
Q3 FY26 Highlights
9M FY26 Performance
The company achieved its highest-ever annual PAT within nine months, underscoring strong operating leverage and margin expansion.
Segment & Regional Highlights
Product-wise growth (Q3 FY26):
Europe emerged as the standout region, with 123% YoY growth in Q3.
Rallis India Limited (a Tata Enterprise) reported strong volume-led growth in Q3 FY26, with improved operational performance across businesses.
Q3 FY26 Performance
Growth was driven by strong volume traction across Crop Care, Seeds, and B2B businesses, supported by improved field activity and customer engagement.
9M FY26 Performance
Improved gross contribution and operating efficiencies supported sustained profitability growth during the nine-month period.
Business & Strategic Highlights
Tagros Chemicals India Pvt. Ltd. has signed a definitive agreement to acquire the global Flubendiamide insecticide business assets from Bayer AG, covering markets across Latin America, Europe, the Middle East & Africa, and Asia-Pacific. The acquisition provides Tagros with immediate access to more than 25 international markets and strengthens its position in the fast-growing diamide insecticide segment.
The deal includes solo and mixture formulations, product registrations, regulatory data, technical documentation, and associated inventories. Tagros will also acquire globally recognized brands including BELT, FAME, FENOS, FENOS QUICK, BELT EXPERT, and TIHAN, which are widely used for controlling lepidopteran pests in crops such as rice, cotton, vegetables, pulses, and fruits.
The acquisition supports Tagros’ strategic transition from a predominantly B2B active ingredient manufacturer to an integrated global agrochemical player. The company has been expanding its capabilities in diamide chemistry, including in-house development and manufacturing of chlorantraniliprole (CTPR), while also planning to introduce additional diamide molecules such as bromocyanamide in the coming months.
The transaction also marks Tagros’ entry into the branded B2C crop protection segment. The acquired formulations portfolio will be managed under Arqivo, Tagros’ newly established entity focused on branded agrochemical solutions and direct farmer engagement.
Leveraging its strong manufacturing base and backward integration capabilities, Tagros plans to build a fully integrated flubendiamide production chain and expand its global crop protection footprint while building on Bayer’s established market presence for the product.
At Nova Agritech Limited, Soil Health Management and Biostimulants are the two largest revenue-generating segments within the company’s agri-input portfolio. In FY 2024–25, Soil Health Management accounted for INR 55.23 crore in sales, contributing 33.30% of total revenue, making it the company’s largest segment. This was followed by Biostimulants, which generated INR 49.46 crore and contributed 29.82% of revenue, highlighting the increasing importance of sustainable and productivity-enhancing agricultural inputs in the company’s product mix.
To support growth across these key segments, Nova Agritech commissioned new manufacturing facilities in Telangana for both Nova Agritech and its subsidiary NASPL, funded through INR 24.69 crore from IPO proceeds. This expansion increased the company’s manufacturing capacity to 14,592 MTPA for Nova Agritech and 13,269.6 MTPA for NASPL, with current utilization levels around 48%, providing significant headroom to meet future demand.
Following the commissioning of this facility, the Telangana Government granted a license amendment in January 2026 allowing the company to manufacture biostimulants at the same formulation plant. This regulatory approval enables the company to expand its product range and utilize the expanded manufacturing infrastructure to produce biostimulants alongside its existing agricultural inputs.
Overall, the capacity expansion and regulatory approval strengthen Nova Agritech’s manufacturing capabilities, reduce reliance on third-party manufacturers, and support the company’s strategy to expand its presence across soil health management, biostimulants, crop nutrition, and crop protection solutions, positioning it to capitalize on the growing demand for sustainable agricultural inputs.
The Government of India is preparing to introduce new legislation on seeds and pesticides aimed at protecting farmers from substandard and counterfeit agricultural inputs. The announcement was made by Shivraj Singh Chouhan, Union Minister of Agriculture and Farmers’ Welfare, during a farmers’ fair held in Kumhari in Durg district, Chhattisgarh.
Addressing farmers at the event, the minister highlighted that fake fertilisers, spurious pesticides, and substandard seeds remain major challenges for cultivators, often leading to financial losses and lower crop productivity. He stated that the Centre is working to introduce a new Seed Act in Parliament during the current session, which will impose strict penalties on companies or individuals supplying fake or substandard seeds. The proposed legislation will include heavy fines and punitive provisions against offenders who deliberately exploit farmers by selling poor-quality inputs.
In addition to the Seed Act, the government is also drafting a new Pesticide Act aimed at addressing the growing issue of inferior or ineffective pesticides in the market. According to Chouhan, farmers frequently invest significant amounts in pesticides that fail to deliver results, and the upcoming law will ensure stronger regulatory oversight and strict action against suppliers of substandard pesticides.
The minister also warned that forcing farmers to purchase pesticides or other agricultural products along with fertilisers will be treated as illegal, and authorities will take strict action against those involved in such practices.
During the farmers’ fair, the minister also encouraged farmers to adopt modern agricultural practices, including the use of improved seed varieties, advanced farming technologies, and the cultivation of high-value crops such as fruits, vegetables, flowers, and medicinal plants to improve productivity and income.
Alongside regulatory measures, the government reiterated its commitment to support agricultural research and innovation, with the objective of improving the quality, reliability, and effectiveness of farming inputs available to cultivators.
The proposed reforms are expected to strengthen quality control in India’s agricultural input market, safeguard farmer interests, and promote the adoption of reliable and effective seeds and crop protection products.
Indian agrochemical companies are increasingly strengthening their portfolios through acquisitions of products and technologies from multinational corporations (MNCs), signalling a shift in the country’s crop protection industry. The trend is being driven by expiring patents on several agrochemical molecules and evolving global manufacturing dynamics.
A recent example is Tagros Chemicals’ acquisition of Bayer AG’s Flubendiamide (FLB) insecticide business, including key brands and formulations. The molecule, widely used to control lepidopteran pests in crops such as rice and cotton, will now be marketed under Tagros’ new entity, Arquivo, marking the company’s entry into branded formulations and strengthening its B2C presence.
Similar transactions have taken place across the industry. In 2025, Dhanuka Agritech acquired the manufacturing and distribution rights for Bayer’s fungicides Iprovalicarb and Triadimenol for INR 165 crore, enabling the company to expand into more than 20 global markets. In another strategic move, Coromandel International acquired a 53% stake in NACL Industries for INR 820 crore, enhancing its crop protection portfolio with formulations tied to multinational technologies.
Industry experts note that these partnerships and acquisitions help local companies indigenise advanced crop protection technologies, reduce import dependence, and expand domestic manufacturing. Increased local production could lower the cost of agrochemical inputs and improve accessibility for farmers while enabling product customisation for India’s specific crop and climate conditions.
Despite the growing collaboration between Indian firms and global players, multinational companies remain cautious about deeper investments in India due to regulatory challenges. The approval process for new agrochemical molecules can take six to ten years in India, compared with roughly three years in many other markets, creating uncertainty for innovation-led companies.
India’s agrochemical sector has grown rapidly in recent years, with exports nearly tripling to $3.3 billion in FY25 from $1.3 billion in FY15. The country is now the third-largest exporter of agrochemicals globally, while the domestic market is valued at approximately INR 69,000 crore, with insecticides, herbicides, and fungicides dominating demand.
Overall, the increasing collaboration between Indian agrochemical firms and multinational companies is reshaping the crop protection landscape. While regulatory hurdles persist, the trend is expected to enhance domestic manufacturing capabilities, encourage innovation, and improve access to affordable crop protection solutions for farmers.
Navin Fluorine International Limited (NFIL) has commenced commercial production at its new Anhydrous Hydrofluoric Acid (AHF) manufacturing facility in Dahej, Gujarat, marking a key milestone in the company’s ongoing capacity expansion strategy. The new plant, developed with an investment of approximately INR 450 crore, has an annual production capacity of 40,000 tonnes and is operated through a subsidiary of the company.
The commissioning of the Dahej facility significantly expands NFIL’s AHF production capacity, which was previously limited to 20,000 tonnes per annum at its Surat plant. The additional capacity is expected to enhance supply reliability and support growing demand across multiple industries, including pharmaceuticals, agrochemicals, specialty chemicals, and renewable energy applications.
This development forms part of Navin Fluorine’s broader capital expenditure programme of approximately INR 14 billion aimed at strengthening its integrated fluorine chemistry platform. Under this ongoing capex plan, INR 4.5 billion has been allocated for the Dahej AHF project. Other major projects include INR 5.4 billion invested in an agrochemical intermediate facility scheduled for commissioning in October 2024, INR 0.84 billion for an R32 refrigerant plant in Surat expected by February 2025, and INR 2.9 billion for the development of the cGMP4 manufacturing plant at Dewas.
The company noted that these investments are designed to support long-term growth through FY27 and beyond by expanding its manufacturing capabilities and enhancing its position in high value fluorochemicals. The Dahej facility also represents a strategic step in building scale-driven and future-ready production infrastructure while reinforcing NFIL’s presence across specialty chemicals markets.
Looking ahead, Navin Fluorine indicated that it will evaluate additional investment opportunities by mid-next year, focusing on projects that align with its long-term strategy and sustainability goals over the coming decade.
BioPrime AgriSolutions has received regulatory approval from the Ministry of Agriculture and Farmers’ Welfare for its entire portfolio of more than 20 biostimulant formulations. The clearance, granted by the INM Biostimulant Cell, covers products for both foliar and granular applications.
The approved portfolio spans key biostimulant categories including humic and fulvic acids, seaweed extracts, botanicals, amino acid formulations, and proprietary biological combinations. With this approval, the Pune-based agricultural biotechnology firm joins a select group of companies in India with a fully compliant and broad biological inputs portfolio.
According to CEO and Co-Founder Renuka Diwan, the milestone demonstrates how high-science biological innovations can move from laboratory research to field-level deployment within structured regulatory frameworks. The products are designed to enhance soil health, improve nutrient-use efficiency, strengthen crop resilience to environmental stress, and support sustainable agricultural productivity as demand for science-backed regenerative agriculture solutions continues to grow.
The ICAR–National Research Institute for Integrated Pest Management (ICAR-NRIIPM), New Delhi, has initiated a project to develop an Integrated Pest Management (IPM) module for sustainable production of Gundu Malligai (Jasminum sambac) in Madurai, Tamil Nadu. The project, running from August 2025 to March 2028, is being implemented at the Tamil Nadu Agricultural University (TNAU) in collaboration with the Department of Horticulture, Madurai.
The IPM module integrates biological control agents (Pseudomonas, Bacillus, Trichoderma), beneficial microbes, botanicals such as neem oil (1000 ppm), and eco-friendly insecticides to manage major jasmine pests. As part of the initiative, 40 organic jasmine farmers from two villages in Madurai district are demonstrating IPM practices across 20 acres, supported with training and inputs. The project also includes continuous monitoring of soil health, plant health, and pest incidence to refine sustainable pest management strategies.
Syngenta has expanded its Global Capability Center (GCC) in Pune, strengthening its role in AI-driven digital innovation and global operations. The facility, which employs over 1,100 professionals, supports Syngenta’s worldwide functions across finance, IT, digital services, and AMEA regional operations.
The expansion will accelerate the deployment of AI-powered solutions and data science capabilities to enhance operational efficiency and support the company’s digital transformation strategy. The GCC also provides employees with global exposure, cross-functional roles, and structured career development opportunities.
The move marks a key milestone in Syngenta’s decade-long presence in Pune, reinforcing the city’s growing importance as a global hub for agricultural technology and innovation.
Koppert Sustainable Solutions India Limited (KoSSIL), a joint venture between AgriLife India and Netherlands-based Koppert BV, has inaugurated one of the world’s largest single-site mycorrhiza production facilities at IDA Bollaram, Hyderabad.
The expanded biological manufacturing unit will scale up the production of mycorrhizal fungi beneficial soil microorganisms that enhance plant nutrient and water uptake, improve soil health, and support crop resilience. The facility will supply biological inputs to both domestic and international markets.
The inauguration was led by Aron Oosthoek, Managing Director of Reka BV Group. According to Dr. Venkatesh Devanur, Managing Director of AgriLife India, the facility is the result of over a decade of indigenous R&D in India, covering strain isolation, screening, and large-scale production of mycorrhizal products.
The expansion strengthens Koppert’s local manufacturing capabilities and supports the growing adoption of biological crop inputs as agriculture shifts toward sustainable and soil-centric farming practices.
India and the European Union concluded the India–EU Free Trade Agreement (FTA) at the 16th India–EU Summit, marking a major step in strengthening bilateral trade between the two economies. The agreement provides preferential access for more than 99% of Indian exports to the EU, while bilateral trade in goods between the two partners reached USD 136.54 billion in 2024–25, including USD 75.85 billion in Indian exports.
The agreement is expected to benefit several sectors, including chemicals and agricultural inputs. For the agrochemical industry, improved market access to the EU could support higher exports of crop protection products and intermediates.
According to official trade data from UN Comtrade / World Bank WITS, India exported around USD 1.55 billion worth of insecticides (HS 380810) globally in 2024. European countries already import a share of these products, with Belgium importing about USD 53 million, making it one of the key EU entry points for Indian agrochemical shipments.
On the demand side, Eurostat reports that 292,000 tonnes of pesticides were sold across the European Union in 2023, highlighting the scale of the region’s crop protection market. Improved tariff access under the FTA could therefore enhance India’s competitiveness in supplying pesticides and related agrochemical products to European markets.
The agreement also includes provisions to address non-tariff barriers, regulatory cooperation, and sanitary and phytosanitary standards, which are critical for agricultural inputs such as pesticides and plant protection products. These measures are expected to facilitate smoother trade flows and support integration of Indian chemical and agrochemical manufacturers into European supply chains.
Overall, the India–EU FTA is expected to strengthen trade linkages between the two economies and create new opportunities for India’s agrochemical sector by improving market access, reducing trade barriers and supporting participation in global value chains.
FMC Corporation is planning to divest its India commercial operations as part of a broader restructuring strategy aimed at strengthening its balance sheet and focusing on higher-margin global markets. The company has classified its India commercial business as “held for sale,” with the divestment process expected to be completed within about 12 months.
The unit includes a branded crop protection portfolio, nationwide sales and distribution network, and established relationships with distributors and farmers, and is estimated to be valued at around $450 million. Several Indian agrochemical companies, including UPL Limited, Dhanuka Agritech, Coromandel International, and Crystal Crop Protection, are reportedly evaluating bids.
The decision follows weak demand and high inventory levels in the crop protection market, which have affected FMC’s performance since 2023. The company has also revised its 2025 net sales forecast to $4.08–$4.28 billion, slightly below its earlier guidance of $4.15–$4.35 billion.
Despite the planned exit, FMC India continues to operate its business during the transition period. In December 2025, the company launched three new paddy-focused products: Resonex™ insecticide (AQRION™ technology) for stem borer control, Rhyme™ fungicide (flutriafol) for sheath blight management, and Vytegris® BO-LA, a boron-based crop nutrition solution designed to improve nutrient uptake and yield potential.
FMC will continue its active ingredient manufacturing operations in India and may enter into supply agreements with the eventual buyer, ensuring continued participation in the Indian agricultural inputs market, while the newly launched products will likely become part of the portfolio and assets transferred to the buyer as part of the divestment.